Hax-1: A regulator of calcium signaling and apoptosis progression with multiple roles in human disease

Expert Opinion on Therapeutic Targets

Volumn 15, Issue 6, 2011, Pages 741-751

  Simmen, Thomas ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

calcium; endoplasmic reticulum; Hax 1; mitochondria; SERCA

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE 3; GRANULOCYTE COLONY STIMULATING FACTOR; GRANZYME B; POLYCYSTIN 2; PROTEIN HAX 1; PROTEINASE; REGULATOR PROTEIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS ENZYME; VPR PROTEIN; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; CALCIUM SIGNALING; CANCER CELL CULTURE; DRUG TARGETING; HUMAN; NEOPLASM; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVIEW; SEVERE CONGENITAL NEUTROPENIA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCIUM SIGNALING; DRUG DELIVERY SYSTEMS; HUMANS; NEOPLASMS; NEUTROPENIA; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 79955870887     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.2011.561787     Document Type: Review

References (97)

1. Suzuki Y, Demoliere C, Kitamura D, et al. HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J Immunol 1997;158(6):2736-44 (Pubitemid 127470532)
2. Hao JJ, Zhu J, Zhou K, et al. The coiled-coil domain is required for HS1 to bind to F-actin and activate Arp2/3 complex. J Biol Chem 2005;280(45):37988- 94 (Pubitemid 41642412)
3. Uruno T, Zhang P, Liu J, et al. Haematopoietic lineage cell-specific protein 1 (HS1) promotes actin-related protein (Arp) 2/3 complex-mediated actin polymerization. Biochem J 2003;371(Pt 2):485-93 (Pubitemid 36547632)
4. Huang Y, Comiskey EO, Dupree RS, et al. The c-Abl tyrosine kinase regulates actin remodeling at the immune synapse. Blood 2008;112(1):111-19
5. Yamanashi Y, Fukuda T, Nishizumi H, et al. Role of tyrosine phosphorylation of HS1 in B cell antigen receptor-mediated apoptosis. J Exp Med 1997;185(7):1387-92 (Pubitemid 27172919)
6. Gomez TS, McCarney SD, Carrizosa E, et al. HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse. Immunity 2006;24(6):741-52 (Pubitemid 43867363)
7. Hao JJ, Carey GB, Zhan X. Syk-mediated tyrosine phosphorylation is required for the association of hematopoietic lineage cell-specific protein 1 with lipid rafts and B cell antigen receptor signalosome complex. J Biol Chem 2004;279(32):33413-20 (Pubitemid 39062990)
8. Brunati AM, Deana R, Folda A, et al. Thrombin-induced tyrosine phosphorylation of HS1 in human platelets is sequentially catalyzed by Syk and Lyn tyrosine kinases and associated with the cellular migration of the protein. J Biol Chem 2005;280(22):21029-35 (Pubitemid 40805661)
9. Fukuda T, Kitamura D, Taniuchi I, et al. Restoration of surface IgM-mediated apoptosis in an anti-IgM-resistant variant of WEHI-231 lymphoma cells by HS1, a protein-tyrosine kinase substrate. Proc Natl Acad Sci USA 1995;92(16):7302-6
10. Peckl-Schmid D, Wolkerstorfer S, Konigsberger S, et al. HAX1 deficiency: impact on lymphopoiesis and B-cell development. Eur J Immunol 2010;40(11):3161-72
11. Jeyaraju DV, Cisbani G, De Brito OM, et al. Hax1 lacks BH modules and is peripherally associated to heavy membranes: implications for Omi/HtrA2 and PARL activity in the regulation of mitochondrial stress and apoptosis. Cell Death Differ 2009;16(12):1622-9
12. Yap SV, Vafiadaki E, Strong J, et al. HAX-1: a multifaceted antiapoptotic protein localizing in the mitochondria and the sarcoplasmic reticulum of striated muscle cells. J Mol Cell Cardiol 2010;48(6):1266-79
13. Van Rossum AG, Schuuring-Scholtes E, van Buuren-van Seggelen V, et al. Comparative genome analysis of cortactin and HS1: the significance of the F-actin binding repeat domain. BMC Genomics 2005;6(1):15
14. Grzybowska EA, Sarnowska E, Konopinski R, et al. Identification and expression analysis of alternative splice variants of the rat Hax-1 gene. Gene 2006;371(1):84-92
15. Hippe A, Bylaite M, Chen M, et al. Expression and tissue distribution of mouse Hax1. Gene 2006;379:116-26 (Pubitemid 44247332)
16. Sharp TV, Wang HW, Koumi A, et al. K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol 2002;76(2):802-16 (Pubitemid 34033378)
17. Li WB, Feng J, Geng SM, et al. Induction of apoptosis by Hax-1 siRNA in melanoma cells. Cell Biol Int 2009;33(4):548-54
18. Jitkaew S, Trebinska A, Grzybowska E, et al. N(alpha)-tosyl-L- phenylalanine chloromethyl ketone induces caspase-dependent apoptosis in transformed human B cell lines with transcriptional down-regulation of anti-apoptotic HS1-associated protein X-1. J Biol Chem 2009;284(41):27827-37
19. Han J, Goldstein LA, Hou W, et al. Deregulation of mitochondrial membrane potential by mitochondrial insertion of granzyme B and direct Hax-1 cleavage. J Biol Chem 2010;285(29):22461-72
20. Lee AY, Lee Y, Park YK, et al. HS 1-associated protein X-1 is cleaved by caspase-3 during apoptosis. Mol Cells 2008;25(1):86-90 (Pubitemid 351611842)
21. Fadeel B, Grzybowska E. HAX-1: a multifunctional protein with emerging roles in human disease. Biochim Biophys Acta 2009;1790(10):1139-48
22. Modem S, Reddy TR. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization. J Cell Physiol 2008;214(1):14-19 (Pubitemid 350220054)
23. Trebinska A, Rembiszewska A, Ciosek K, et al. HAX-1 overexpression, splicing and cellular localization in tumors. BMC Cancer 2010;10:76
24. Yin H, Morioka H, Towle CA, et al. Evidence that HAX-1 is an interleukin-1 alpha N-terminal binding protein. Cytokine 2001;15(3):122-37 (Pubitemid 34587494)
25. Al-Maghrebi M, Brule H, Padkina M, et al. The 3¢ untranslated region of human vimentin mRNA interacts with protein complexes containing eEF-1gamma and HAX-1. Nucleic Acids Res 2002;30(23):5017-28 (Pubitemid 36033019)
26. Sarnowska E, Grzybowska EA, Sobczak K, et al. Hairpin structure within the 3¢UTR of DNA polymerase beta mRNA acts as a post-transcriptional regulatory element and interacts with Hax-1. Nucleic Acids Res 2007;35(16):5499-510 (Pubitemid 47423923)
27. Chao JR, Parganas E, Boyd K, et al. Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons. Nature 2008;452(7183):98-102 (Pubitemid 351355088)
28. Vafiadaki E, Arvanitis DA, Pagakis SN, et al. The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival. Mol Biol Cell 2009;20(1):306-18
29. Vafiadaki E, Sanoudou D, Arvanitis DA, et al. Phospholamban interacts with HAX-1, a mitochondrial protein with anti-apoptotic function. J Mol Biol 2007;367(1):65-79 (Pubitemid 46274703)
30. Zhao W, Waggoner JR, Zhang ZG, et al. The anti-apoptotic protein HAX-1 is a regulator of cardiac function. Proc Natl Acad Sci USA 2009;106(49):20776-81
31. Cilenti L, Soundarapandian MM, Kyriazis GA, et al. Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J Biol Chem 2004;279(48):50295-301 (Pubitemid 39577845)
32. Matsuda G, Nakajima K, Kawaguchi Y, et al. Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1. Microbiol Immunol 2003;47(1):91-9 (Pubitemid 36119656)
33. Han Y, Chen YS, Liu Z, et al. Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circ Res 2006;99(4):415-23 (Pubitemid 44253698)
34. Kang YJ, Jang M, Park YK, et al. Molecular interaction between HAX-1 and XIAP inhibits apoptosis. Biochem Biophys Res Commun 2010;393(4):794-9
35. Jacotot E, Ravagnan L, Loeffler M, et al. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med 2000;191(1):33-46
36. Yedavalli VS, Shih HM, Chiang YP, et al. Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1. J Virol 2005;79(21):13735-46 (Pubitemid 41508185)
37. Banerjee A, Saito K, Meyer K, et al. Hepatitis C virus core protein and cellular protein HAX-1 promote 5-fluorouracil-mediated hepatocyte growth inhibition. J Virol 2009;83(19):9663-71
38. Dufva M, Olsson M, Rymo L. Epstein-Barr virus nuclear antigen 5 interacts with HAX-1, a possible component of the B-cell receptor signalling pathway. J Gen Virol 2001;82(Pt 7):1581-7 (Pubitemid 32611498)
39. Johns HL, Doceul V, Everett HE, et al. The classical swine fever virus N-terminal protease Npro binds to cellular HAX-1. J Gen Virol 2010;91(Pt 11):2677-86
40. Jones JM, Datta P, Srinivasula SM, et al. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 2003;425(6959):721-7 (Pubitemid 37314315)
41. Martins LM, Morrison A, Klupsch K, et al. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol Cell Biol 2004;24(22):9848-62 (Pubitemid 39458812)
42. Kasashima K, Ohta E, Kagawa Y, et al. Mitochondrial functions and estrogen receptor-dependent nuclear translocation of pleiotropic human prohibitin 2. J Biol Chem 2006;281(47):36401-10 (Pubitemid 46041374)
43. Osman C, Merkwirth C, Langer T. Prohibitins and the functional compartmentalization of mitochondrial membranes. J Cell Sci 2009;122(Pt 21):3823-30
44. Merkwirth C, Dargazanli S, Tatsuta T, et al. Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev 2008;22(4):476-88 (Pubitemid 351272755)
45. Merkwirth C, Langer T. Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim Biophys Acta 2009;1793(1):27-32
46. Terashima M, Kim KM, Adachi T, et al. The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J 1994;13(16):3782-92 (Pubitemid 24275024)
47. Sharma A, Qadri A. Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. Proc Natl Acad Sci USA 2004;101(50):17492-7 (Pubitemid 39657431)
48. Ruzzene M, Penzo D, Pinna LA. Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells. Biochem J 2002;364(Pt 1):41-7 (Pubitemid 34538944)
49. Gallagher AR, Cedzich A, Gretz N, et al. The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton. Proc Natl Acad Sci USA 2000;97(8):4017-22 (Pubitemid 30226079)
50. Chen XZ, Li Q, Wu Y, et al. Submembraneous microtubule cytoskeleton: interaction of TRPP2 with the cell cytoskeleton. FEBS J 2008;275(19):4675-83
51. Wegierski T, Steffl D, Kopp C, et al. TRPP2 channels regulate apoptosis through the Ca2+ concentration in the endoplasmic reticulum. EMBO J 2009;28(5):490-9
52. Giorgi C, De Stefani D, Bononi A, et al. Structural and functional link between the mitochondrial network and the endoplasmic reticulum. Int J Biochem Cell Biol 2009;41(10):1817-27
53. Pinton P, Giorgi C, Siviero R, et al. Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene 2008;27(50):6407-18
54. Boehning D, Patterson RL, Sedaghat L, et al. Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol 2003;5(12):1051-61 (Pubitemid 37509111)
55. Boehning D, Patterson RL, Snyder SH. Apoptosis and calcium: new roles for cytochrome c and inositol 1,4,5-trisphosphate. Cell Cycle 2004;3(3):252-4 (Pubitemid 41359065)
56. Sammels E, Devogelaere B, Mekahli D, et al. Polycystin-2 activation by inositol 1,4,5-trisphosphate-induced Ca2+ release requires its direct association with the inositol 1,4,5-trisphosphate receptor in a signaling microdomain. J Biol Chem 2010;285(24):18794-805
57. Brini M, Carafoli E. Calcium pumps in health and disease. Physiol Rev 2009;89(4):1341-78
58. Tada M, Toyofuku T. Molecular regulation of phospholamban function and expression. Trends Cardiovasc Med 1998;8(8):330-40 (Pubitemid 28565197)
59. de Brito OM, Scorrano L. An intimate liaison: spatial organization of the endoplasmic reticulum-mitochondria relationship. EMBO J 2010;29(16):2715-23
60. Simmen T, Lynes EM, Gesson K, et al. Oxidative protein folding in the endoplasmic reticulum: tight links to the mitochondria-associated membrane (MAM). Biochim Biophys Acta 2010;1798(8):1465-73
61. Laude AJ, Simpson AW. Compartmentalized signalling: Ca2+ compartments, microdomains and the many facets of Ca2+ signalling. FEBS J 2009;276(7):1800-16
62. Cardenas C, Miller RA, Smith I, et al. Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell 2010;142(2):270-83
63. Camacho P, Lechleiter JD. Increased frequency of calcium waves in Xenopus laevis oocytes that express a calcium-ATPase. Science 1993;260(5105):226-9 (Pubitemid 23140890)
64. Wileman T, Kane LP, Carson GR, et al. Depletion of cellular calcium accelerates protein degradation in the endoplasmic reticulum. J Biol Chem 1991;266(7):4500-7 (Pubitemid 21909385)
65. Foyouzi-Youssefi R, Arnaudeau S, Borner C, et al. Bcl-2 decreases the free Ca2+ concentration within the endoplasmic reticulum. Proc Natl Acad Sci USA 2000;97(11):5723-8 (Pubitemid 30367465)
66. Pinton P, Ferrari D, Magalhaes P, et al. Reduced loading of intracellular Ca(2+) stores and downregulation of capacitative Ca(2+) influx in Bcl-2-overexpressing cells. J Cell Biol 2000;148(5):857-62
67. Dremina ES, Sharov VS, Kumar K, et al. Anti-apoptotic protein Bcl-2 interacts with and destabilizes the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA). Biochem J 2004;383(Pt 2):361-70 (Pubitemid 39446698)
68. Dremina ES, Sharov VS, Schoneich C. Displacement of SERCA from SR lipid caveolae-related domains by Bcl-2: a possible mechanism for SERCA inactivation. Biochemistry 2006;45(1):175-84 (Pubitemid 43054095)
69. Myhill N, Lynes EM, Nanji JA, et al. The subcellular distribution of calnexin is mediated by PACS-2. Mol Biol Cell 2008;19(7):2777-88
70. Roderick HL, Lechleiter JD, Camacho P. Cytosolic phosphorylation of calnexin controls intracellular Ca(2+) oscillations via an interaction with SERCA2b. J Cell Biol 2000;149(6):1235-48
71. Chevet E, Smirle J, Cameron PH, et al. Calnexin phosphorylation: linking cytoplasmic signalling to endoplasmic reticulum lumenal functions. Semin Cell Dev Biol 2010
72. Wegener AD, Simmerman HK, Lindemann JP, et al. Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to beta-adrenergic stimulation. J Biol Chem 1989;264(19):11468- 74 (Pubitemid 19168886)
73. Lees DM, Hart IR, Marshall JF. Existence of multiple isoforms of HS1-associated protein X-1 in murine and human tissues. J Mol Biol 2008;379(4):645-55
74. Kokoszynska K, Rychlewski L, Wyrwicz LS. Distant homologs of anti-apoptotic factor HAX1 encode parvalbumin-like calcium binding proteins. BMC Res Notes 2010;3:197
75. Radhika V, Onesime D, Ha JH, et al. Galpha13 stimulates cell migration through cortactin-interacting protein Hax-1. J Biol Chem 2004;279(47):49406-13 (Pubitemid 39625826)
76. Ramsay AG, Keppler MD, Jazayeri M, et al. HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin alphavbeta6. Cancer Res 2007;67(11):5275-84 (Pubitemid 46997266)
77. Mirmohammadsadegh A, Tartler U, Michel G, et al. HAX-1, identified by differential display reverse transcription polymerase chain reaction, is overexpressed in lesional psoriasis. J Invest Dermatol 2003;120(6):1045-51 (Pubitemid 36702916)
78. de Brito OM, Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008;456(7222):605-10
79. Simmen T, Aslan JE, Blagoveshchenskaya AD, et al. PACS-2 controls endoplasmic reticulum-mitochondria communication and Bid-mediated apoptosis. EMBO J 2005;24(4):717-29 (Pubitemid 40396102)
80. Meunier J, Hayashi T. Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB. J Pharmacol Exp Ther 2010;332(2):388-97
81. Mori N, Yamada Y, Ikeda S, et al. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 2002;100(5):1828-34 (Pubitemid 34925163)
82. Boztug K, Klein C. Novel genetic etiologies of severe congenital neutropenia. Curr Opin Immunol 2009;21(5):472-80
83. Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2007;39(1):86-92 (Pubitemid 46026506)
84. Carlsson G, Elinder G, Malmgren H, et al. Compound heterozygous HAX1 mutations in a Swedish patient with severe congenital neutropenia and no neurodevelopmental abnormalities. Pediatr Blood Cancer 2009;53(6):1143-6
85. Faiyaz-Ul-Haque M, Al-Jefri A, Abalkhail HA, et al. A novel missense mutation in the HAX1 gene in severe congenital neutropenia patients (Kostmann disease). Clin Genet 2009;76(6):569-72
86. Smith BN, Ancliff PJ, Pizzey A, et al. Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds. Br J Haematol 2009;144(5):762-70
87. Eghbali A, Eshghi P, Malek F, et al. HAX1 mutation in an infant with severe congenital neutropenia. Turk J Pediatr 2010;52(1):81-4
88. Faiyaz-Ul-Haque M, Al-Jefri A, Al-Dayel F, et al. A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations. Eur J Pediatr 2010;169(6):661-6
89. Lanciotti M, Indaco S, Bonanomi S, et al. Novel HAX1 gene mutations associated to neurodevelopment abnormalities in two Italian patients with severe congenital neutropenia. Haematologica 2010;95(1):168-9
90. Carlsson G, van't Hooft I, Melin M, et al. Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med 2008;264(4):388-400
91. Germeshausen M, Grudzien M, Zeidler C, et al. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood 2008;111(10):4954-7
92. Diwan A, Matkovich SJ, Yuan Q, et al. Endoplasmic reticulum-mitochondria crosstalk in NIX-mediated murine cell death. J Clin Invest 2009;119(1):203-12
93. Aytekin C, Germeshausen M, Tuygun N, et al. Eponym. Kostmann disease. Eur J Pediatr 2010;169(6):657-60
94. Carlsson G, Aprikyan AA, Tehranchi R, et al. Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. Blood 2004;103(9):3355-61 (Pubitemid 38525664)
95. Germeshausen M, Skokowa J, Ballmaier M, et al. G-CSF receptor mutations in patients with congenital neutropenia. Curr Opin Hematol 2008;15(4):332-7
96. Zeidler C, Germeshausen M, Klein C, et al. Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia. Br J Haematol 2009;144(4):459-67
97. Carlsson G, Boxhammer S, Garwicz D, et al. Survivin expression in the bone marrow of patients with severe congenital neutropenia. Leukemia 2009;23(3):622-5